Clinical trials recruiting for Advanced Pancreatic Cancers

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
  NCT06760364 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
  NCT07326137 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
  NCT05098197 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
  NCT06770439 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Advanced Pancreatic Cancers often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Advanced Pancreatic Cancers trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.